We are live on ! Find out more
LMIM

Lockheed Martin Investment Management Portfolio holdings

AUM $2.73B
1-Year Est. Return 28.24%
This Fund
S&P 500
This Quarter Est. Return
+5.1%
1 Year Est. Return
+28.24%
3 Year Est. Return
+67.58%
5 Year Est. Return
+76.13%
10 Year Est. Return
+215.14%
AUM
$2.17B
AUM Growth
+$282M
Cap. Flow
+$186M
Cap. Flow %
8.55%
Top 10 Hldgs %
59.38%
Holding
142
New
11
Increased
28
Reduced
61
Closed
16

Top Buys

Rank Stock Value
1
VXF icon
Vanguard Extended Market ETF
VXF
+$82.5M
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$43.3M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$31.9M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$26.8M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$25.8M

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$9.17M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$8.74M
3
BMY icon
Bristol-Myers Squibb
BMY
+$6.16M
4
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$6.13M
5
EFG icon
iShares MSCI EAFE Growth ETF
EFG
+$5.6M

Sector Composition

Rank Sector Weight
1 Technology 3.86%
2 Financials 2.66%
3 Communication Services 1.4%
4 Consumer Discretionary 0.75%
5 Industrials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
126
Teva Pharmaceuticals
TEVA
$40.8B
$189K 0.01%
10,000
-8,000
-44% -$120K
AFL icon
127
Aflac
AFL
$64.9B
– –
-97,400
Closed -$3.96M
ATRC icon
128
AtriCure
ATRC
$1.92B
– –
-36,250
Closed -$811K
BKNG icon
129
Booking.com
BKNG
$149B
– –
-15,000
Closed -$1.1M
BMY icon
130
Bristol-Myers Squibb
BMY
$133B
– –
-96,700
Closed -$6.16M
BX icon
131
Blackstone
BX
$102B
– –
-20,000
Closed -$667K
EVH icon
132
Evolent Health
EVH
$348M
– –
-28,650
Closed -$510K
EW icon
133
Edwards Lifesciences
EW
$49.6B
– –
-25,200
Closed -$918K
GDX icon
134
VanEck Gold Miners ETF
GDX
$22.7B
– –
-150,000
Closed -$3.44M
NTES icon
135
NetEase
NTES
$85.3B
– –
-30,635
Closed -$1.62M
O icon
136
Realty Income
O
$59.6B
– –
-54,386
Closed -$3.01M
PEN icon
137
Penumbra
PEN
$12.7B
– –
-7,600
Closed -$686K
RNR icon
138
RenaissanceRe
RNR
$13.3B
– –
-17,700
Closed -$2.39M
TRV icon
139
Travelers Companies
TRV
$78.1B
– –
-23,150
Closed -$2.84M
NVRO
140
DELISTED
NEVRO CORP.
NVRO
– –
-8,500
Closed -$772K
AGN
141
DELISTED
Allergan plc
AGN
– –
-16,500
Closed -$3.38M
SHPG
142
DELISTED
Shire pic
SHPG
– –
-5,700
Closed -$873K
2 3 4 5
6

Similar funds

GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return

Lockheed Martin Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Lockheed Martin Investment Management held 142 positions worth $2.17B, up 15% from $1.89B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Lockheed Martin Investment Management deployed $186M of net new capital in Q4 2017, opening 11 new positions and adding to 28 existing holdings. Its largest new stake was Vanguard Extended Market ETF: 753,000 shares worth $84.1M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, down from 3.9% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Chubb, an estimated $9.17M trimmed.

  • Lockheed Martin Investment Management's largest Q4 2017 buy was Vanguard Extended Market ETF: 753,000 shares worth $84.1M.
  • Lockheed Martin Investment Management added most to iShares MSCI Emerging Markets ETF in Q4 2017, an estimated $31.9M increase.
  • Lockheed Martin Investment Management's biggest Q4 2017 reduction was Chubb, cutting an estimated $9.17M.
  • Lockheed Martin Investment Management fully exited Bristol-Myers Squibb in Q4 2017, selling an estimated $6.16M.
  • Lockheed Martin Investment Management's ten largest holdings make up 59% of its $2.17B portfolio in Q4 2017.
  • Lockheed Martin Investment Management opened 11 new positions and closed 16 in Q4 2017.
  • Lockheed Martin Investment Management's portfolio value rose 15% quarter-over-quarter to $2.17B.

Based on Lockheed Martin Investment Management's 13F filing for Q4 2017, filed 18 Jan 2018.